Altimmune, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue026K5K5K5K5K5K5K
Cost of Goods Sold23K015.0M00000
Gross Profit-23K26K-15.0M5K5K5K5K5K
R&D Expenses16.2M18.4M15.0M17.2M15.8M19.8M19.8M21.2M
Operating Expenses24.2M28.9M5.9M22.9M21.8M24.9M24.8M26.8M
Operating Income-24.2M-28.9M-20.9M-22.9M-21.8M-24.9M-24.8M-26.7M
Other Income / Gains1.7M1.5M1.8M776K1.6M1.7M1.9M2.1M
Net Income-22.6M-27.4M-19.0M-22.1M-19.6M-23.2M-22.8M-24.6M
EPS (Diluted)-0.18-0.27-0.21-0.27-0.26-0.33-0.32-0.35
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio01.00-3K1.001.001.001.001.00
General And Administrative Expenses8.1M10.5M5.9M5.7M6.0M5.1M5.0M5.6M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses8.1M10.5M5.9M5.7M6.0M5.1M5.0M5.6M
Other Expenses00-15.0M00000
Cost And Expenses24.2M28.9M20.9M22.9M21.8M24.9M24.8M26.8M
Interest Income2.9M2.4M2.4M1.1M1.5M1.6M1.9M2.2M
Interest Expense1.1M876K495K264K1K1K6K1K
Depreciation And Amortization23K26K27K30K29K33K37K61K
Ebitda-21.5M-26.5M-18.5M-21.9M-20.2M-23.1M-22.8M-24.6M
Ebitdaratio0-1K-4K-4K-4K-5K-5K-5K
Operating Income Ratio0-1K-4K-5K-4K-5K-5K-5K
Income Before Tax-22.6M-27.4M-19.0M-22.1M-20.3M-23.2M-22.8M-24.6M
Income Before Tax Ratio0-1K-4K-4K-4K-5K-5K-5K
Income Tax Expense0000-681K000
Net Income Ratio0-1K-4K-4K-4K-5K-5K-5K
Epsdiluted-0.18-0.27-0.21-0.27-0.26-0.33-0.32-0.35
Weighted Average Shs Out124.5M100.6M89.4M81.5M75.5M71.3M71.1M70.9M
Weighted Average Shs Out Dil124.5M100.6M89.4M81.5M75.5M71.3M71.1M70.9M